Fennec Pharmaceuticals Stock Market Value
FENC Stock | USD 7.58 0.54 7.67% |
Symbol | Fennec |
Fennec Pharmaceuticals Price To Book Ratio
Is Fennec Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fennec Pharmaceuticals. If investors know Fennec will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fennec Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.04 | Revenue Per Share 1.684 | Quarterly Revenue Growth 14.132 | Return On Assets 0.0857 | Return On Equity (10.06) |
The market value of Fennec Pharmaceuticals is measured differently than its book value, which is the value of Fennec that is recorded on the company's balance sheet. Investors also form their own opinion of Fennec Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Fennec Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fennec Pharmaceuticals' market value can be influenced by many factors that don't directly affect Fennec Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fennec Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Fennec Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fennec Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Fennec Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Fennec Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Fennec Pharmaceuticals.
04/20/2024 |
| 05/20/2024 |
If you would invest 0.00 in Fennec Pharmaceuticals on April 20, 2024 and sell it all today you would earn a total of 0.00 from holding Fennec Pharmaceuticals or generate 0.0% return on investment in Fennec Pharmaceuticals over 30 days. Fennec Pharmaceuticals is related to or competes with HUMANA, Barloworld, Morningstar Unconstrained, and High Yield. Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company More
Fennec Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Fennec Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Fennec Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
Information Ratio | (0.10) | |||
Maximum Drawdown | 38.11 | |||
Value At Risk | (3.14) | |||
Potential Upside | 2.86 |
Fennec Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Fennec Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Fennec Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Fennec Pharmaceuticals historical prices to predict the future Fennec Pharmaceuticals' volatility.Risk Adjusted Performance | (0.04) | |||
Jensen Alpha | (0.33) | |||
Total Risk Alpha | (0.94) | |||
Treynor Ratio | (2.62) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Fennec Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Fennec Pharmaceuticals Backtested Returns
Fennec Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.0626, which denotes the company had a -0.0626% return per unit of risk over the last 3 months. Fennec Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Fennec Pharmaceuticals' Mean Deviation of 2.1, variance of 16.42, and Standard Deviation of 4.05 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.12, which means not very significant fluctuations relative to the market. As returns on the market increase, Fennec Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Fennec Pharmaceuticals is expected to be smaller as well. Fennec Pharmaceuticals has an expected return of -0.26%. Please make sure to confirm Fennec Pharmaceuticals maximum drawdown, daily balance of power, period momentum indicator, as well as the relationship between the skewness and day typical price , to decide if Fennec Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.27 |
Poor predictability
Fennec Pharmaceuticals has poor predictability. Overlapping area represents the amount of predictability between Fennec Pharmaceuticals time series from 20th of April 2024 to 5th of May 2024 and 5th of May 2024 to 20th of May 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Fennec Pharmaceuticals price movement. The serial correlation of 0.27 indicates that nearly 27.0% of current Fennec Pharmaceuticals price fluctuation can be explain by its past prices.
Correlation Coefficient | 0.27 | |
Spearman Rank Test | 0.21 | |
Residual Average | 0.0 | |
Price Variance | 1.35 |
Fennec Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Fennec Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Fennec Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Fennec Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Fennec Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
Fennec Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Fennec Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Fennec Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Fennec Pharmaceuticals stock over time.
Current vs Lagged Prices |
Timeline |
Fennec Pharmaceuticals Lagged Returns
When evaluating Fennec Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Fennec Pharmaceuticals stock have on its future price. Fennec Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Fennec Pharmaceuticals autocorrelation shows the relationship between Fennec Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Fennec Pharmaceuticals.
Regressed Prices |
Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Fennec Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Fennec Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Fennec Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Fennec Pharmaceuticals Stock:Check out Fennec Pharmaceuticals Correlation, Fennec Pharmaceuticals Volatility and Fennec Pharmaceuticals Alpha and Beta module to complement your research on Fennec Pharmaceuticals. For information on how to trade Fennec Stock refer to our How to Trade Fennec Stock guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Fennec Stock analysis
When running Fennec Pharmaceuticals' price analysis, check to measure Fennec Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fennec Pharmaceuticals is operating at the current time. Most of Fennec Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Fennec Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fennec Pharmaceuticals' price. Additionally, you may evaluate how the addition of Fennec Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Stocks Directory Find actively traded stocks across global markets | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |
Fennec Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.